Meta Shares 10 Health Research Manuscripts Built With Muse Models in Four Weeks
Medical researchers used Muse Spark 1.3 and Muse Wonder to produce 10 manuscripts from 5 million de-identified health records. Independent reviewers say the

Meta has shared 10 research manuscripts that medical researchers produced in four weeks with help from its Muse models, the company disclosed on Wednesday. The work tested whether AI models built for agentic tasks could accelerate health data science, with human experts keeping control of the scientific decisions.
The researchers worked inside a human-led scaffold powered by Muse Spark 1.3 and Muse Wonder, according to Meta’s AI at Meta team. The system could draw on publicly available data and a licensed database of 5 million retrospective, de-identified electronic health records. The records came from past care, not from a new clinical trial. Meta’s chief AI officer Alexandr Wang quote-posted the AI at Meta announcement on X, writing that the papers were “all written with muse models in under 4 weeks” and calling health one of the areas where Muse could have its greatest positive impact.
The manuscripts span cardiology, oncology, infectious disease, and emergency medicine, according to Meta. Meta recruited medical researchers with backgrounds in cardiology, epidemiology, infectious disease, and internal medicine. The models helped generate hypotheses, write and execute code, and draft manuscripts. The experts decided the cohorts, variables, methods, and interpretations.
Reviewers Found Leads, Not New Guidance
Meta says each manuscript went through peer feedback within the research cohort, a biostatistician’s review of the analysis, and summary reviews by contracted independent experts, published alongside the papers. Those reviews were substantive rather than ceremonial, according to Superpower Daily’s account of the release.
One manuscript examined heart-rhythm diagnoses after infective endocarditis, an infection of the heart’s inner lining and valves. Meta’s summary gives a one-year risk of 7%, compared with 4% among patients with bloodstream infections without endocarditis. The reviewer, Michael Farbaniec, a Penn State cardiologist, praised the study’s methods but said differences in cardiac monitoring remained a possible explanation for the finding, since more monitoring could reveal more diagnoses. He characterized the result as hypothesis-generating rather than practice-changing.
Another manuscript compared behavioral-health emergency patients who left without being seen with those who completed care. Meta’s summary reports higher rates of return visits, admission, and short-term mortality among those who left. The reviewer, Rohini Downs, a psychiatric pharmacist at Parkland Health & Hospital System, praised the large population but said the analysis lacked adjustments for other factors that could affect the outcomes, along with details about diagnoses, illness severity, and why patients departed.
A diabetes manuscript found that documented remission ended more often through restarting treatment than through rising blood sugar, but the retrospective study could not establish causation or why treatment restarted. Its proposed contribution is narrower: reporting those two outcomes separately and explaining how remission and treatment cessation were confirmed.
Why It Matters
The release is a concrete test of the professional pitch behind Muse Wonder, which Meta positioned at launch for sustained work in law, finance, and health. It also follows independent evaluations of the model, including a DualEntry accounting benchmark where Wonder tied for second among 57 models. Health research is a harder proving ground than accounting, because the data is messier and the cost of a wrong conclusion is higher.
Ten manuscripts in four weeks is a real acceleration of the research workflow: hypothesis generation, code execution, and drafting. The expert reviews show where that acceleration stops. Retrospective records can surface questions worth pursuing, but they cannot by themselves show that patient care should change. The manuscripts and the accompanying expert reviews are available through Meta’s research blog, and the test now is whether any of the leads survive prospective follow-up.


